Dodge & Cox
NVO

Dodge & Cox’s Novo Nordisk NVO Stock Holding History

Dodge & Cox’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$978M Buy
20,397,110
+1,063,360
+6% +$45.7M 0.51% 65
2026
Q1 		$711M Buy
+19,333,750
New +$916M 0.39% 75

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Dodge & Cox's NVO Position: Q2 2026 in Review

Dodge & Cox increased its Novo Nordisk (NVO) stake by 5.5% in Q2 2026, buying an estimated $45.7M and bringing the position to 20,397,110 shares worth $978M. The position accounts for 0.51% of the portfolio, ranked #65.

Dodge & Cox first reported a position in NVO in Q1 2026 and has held it in 2 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Dodge & Cox held 20,397,110 shares of Novo Nordisk worth $978M as of Q2 2026.
  • Dodge & Cox bought 1,063,360 Novo Nordisk shares in Q2 2026, an estimated $45.7M.
  • Novo Nordisk made up 0.51% of Dodge & Cox's portfolio in Q2 2026, its #65 holding.
  • Dodge & Cox first reported a position in Novo Nordisk in Q1 2026 and has held it in 2 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.